Marinus Pharmaceuticals Inc (FRA:61Y)
€ 0.302 0.002 (0.67%) Market Cap: 17.09 Mil Enterprise Value: 30.25 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Marinus Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 26, 2021 / 01:30PM GMT
Release Date Price: €14.4 (+2.13%)
Scott N. Braunstein
Marinus Pharmaceuticals, Inc. - CEO, President & Director

Good morning, and welcome to Marinus Pharmaceuticals 2021 Annual Meeting of Stockholders. I am Scott Braunstein, Chief Executive Officer and a Director of Marinus, and I will be presiding over this meeting.

It is now 9:30 a.m., and I call the meeting to order.

We are also joined by Steven Pfanstiel, our Chief Financial Officer; Martha Manning, our Vice President, General Counsel and Corporate Secretary; and Sasha Damouni Ellis, Vice President, Investor and Corporate Communications.

In addition, we have with us today our -- from our Board of Directors, Nicole Vitullo, Chairperson of the Board; Chuck Austin; Mike Dougherty; Elan Ezickson; Seth Fischer; and Sara Nochur. And from Ernst & Young LLP, Marinus' independent registered public accounting firm, we have Ryan Carrozza, who is available to respond to questions.

Ms. Manning will serve as Secretary of the meeting as well as the Inspector of Elections. Ms. Manning previously took her oath to serve as Inspector of Elections. A copy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot